Clinical Outcome of Pacemaker paTIents According to Pacing Modality and Primary INDications OPTI-MIND 2

NCT01715558 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 514

Last updated 2017-05-09

No results posted yet for this study

Summary

The purpose of the study is to demonstrate that reduction of unnecessary pacing provided by RYTHMIQ algorithm programed to ON in a pacemaker is associated with better clinical outcomes in bradycardia target population.

Conditions

  • Bradyarrhythmia

Sponsors & Collaborators

  • Boston Scientific Corporation

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-02-28
Primary Completion
2016-11-30
Completion
2016-11-30

Countries

  • Belgium
  • Denmark
  • France
  • Germany
  • Italy
  • Netherlands
  • Slovakia
  • Spain
  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01715558 on ClinicalTrials.gov